ACAD
32.11
+0.22
+0.69%
AEMD
1.59
-0.09
-5.36%
APRI
1.35
0.00
0.00%
ARNA
21.27
-0.12
-0.56%
ATEC
1.68
-0.01
-0.59%
CNAT
5.06
-0.1
-1.94%
CRXM
0.159
+0.001
+0.72152%
CYTX
0.35
-0.02
-4.40%
DXCM
71.22
-0.4
-0.56%
GNMK
9.99
-0.1
-0.99%
HALO
11.9
-0.15
-1.24%
ILMN
193.92
-0.88
-0.45%
INNV
0.109
+0.008
+7.921%
INO
5.64
0.00
0.00%
ISCO
1.3
-0.05
-3.70%
ISIS
57.56
0.00
0.00%
LGND
127.02
+0.1
+0.08%
LPTN
2.93
-2.93
-100.00%
MBVX
0.511
-0.04
-7.1818%
MEIP
2.77
-0.02
-0.72%
MNOV
4.69
+0.09
+1.96%
MRTX
4.9
+0.05
+1.03%
MSTX
0.13
-0.01
-5.28%
NBIX
54.04
+0.06
+0.11%
NUVA
68
+1.3
+1.95%
ONCS
0.92
-0.06
-5.93%
ONVO
2.14
-0.04
-1.83%
OREX
2.43
0.00
0.00%
OTIC
19.45
+2.25
+13.08%
QDEL
32.93
-0.22
-0.66%
RCPT
231.96
0.00
0.00%
RGLS
0.882
-0.057
-6.0390%
RMD
72.44
-0.83
-1.13%
SCIE
0
+0.00
+50.0000%
SPHS
1.85
+0.02
+1.09%
SRNE
1.65
-0.12
-7.04%
TROV
0.8
-0.05
-5.66%
VICL
2.41
-0.06
-2.43%
VOLC
18
0.00
0.00%
ZGNX
11.45
+0.2
+1.78%
ACAD
32.11
+0.22
+0.69%
AEMD
1.59
-0.09
-5.36%
APRI
1.35
0.00
0.00%
ARNA
21.27
-0.12
-0.56%
ATEC
1.68
-0.01
-0.59%
CNAT
5.06
-0.1
-1.94%
CRXM
0.159
+0.001
+0.72152%
CYTX
0.35
-0.02
-4.40%
DXCM
71.22
-0.4
-0.56%
GNMK
9.99
-0.1
-0.99%
HALO
11.9
-0.15
-1.24%
ILMN
193.92
-0.88
-0.45%
INNV
0.109
+0.008
+7.921%
INO
5.64
0.00
0.00%
ISCO
1.3
-0.05
-3.70%
ISIS
57.56
0.00
0.00%
LGND
127.02
+0.1
+0.08%
LPTN
2.93
-2.93
-100.00%
MBVX
0.511
-0.04
-7.1818%
MEIP
2.77
-0.02
-0.72%
MNOV
4.69
+0.09
+1.96%
MRTX
4.9
+0.05
+1.03%
MSTX
0.13
-0.01
-5.28%
NBIX
54.04
+0.06
+0.11%
NUVA
68
+1.3
+1.95%
ONCS
0.92
-0.06
-5.93%
ONVO
2.14
-0.04
-1.83%
OREX
2.43
0.00
0.00%
OTIC
19.45
+2.25
+13.08%
QDEL
32.93
-0.22
-0.66%
RCPT
231.96
0.00
0.00%
RGLS
0.882
-0.057
-6.0390%
RMD
72.44
-0.83
-1.13%
SCIE
0
+0.00
+50.0000%
SPHS
1.85
+0.02
+1.09%
SRNE
1.65
-0.12
-7.04%
TROV
0.8
-0.05
-5.66%
VICL
2.41
-0.06
-2.43%
VOLC
18
0.00
0.00%
ZGNX
11.45
+0.2
+1.78%
Home » Events, SDBN Events

SDBN Networking Event Featuring Fate Therapeutics & Stemgent

Submitted by on July 1, 2009 – 11:41 am

The San Diego Biotechnology Network’s July 21st event will feature Fate Therapeutics and Stemgent, two companies engaged in exciting, interdisciplinary biotechnology research in San Diego that holds direct promise for making a difference in our quality of life. Ken Batchelor, Ph.D., CSO, Fate Therapeutics, and Stephen Chang, Ph.D., CSO, Stemgent will present a short talk which will be followed by networking:

CATALYST: The Industrialization of Advanced iPSC Technology for Drug Discovery & Development

For more information visit http://sdbn.org/july

Be Sociable, Share!